Dual-Attack cancer therapy trial seeks to control incurable lymphoma
NCT ID NCT06112847
Summary
This study is testing whether combining two drugs—epcoritamab and lenalidomide—works better than either alone for people with follicular lymphoma who haven't had any prior treatment. The goal is to achieve complete remission and control the disease for as long as possible. About 29 participants will receive both drugs in cycles for up to a year, with doctors closely monitoring their response and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
Conditions
Explore the condition pages connected to this study.